SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-073322
Filing Date
2023-06-21
Accepted
2023-06-21 16:05:47
Documents
4
Effectiveness Date
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2318574d1_s8.htm S-8 47077
2 EXHIBIT 5.1 tm2318574d1_ex5-1.htm EX-5.1 7247
3 EXHIBIT 23.1 tm2318574d1_ex23-1.htm EX-23.1 1914
4 EX-FILING FEES tm2318574d1_ex-filingfees.htm EX-FILING FEES 13363
  Complete submission text file 0001104659-23-073322.txt   70821
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272804 | Film No.: 231029855
SIC: 2835 In Vitro & In Vivo Diagnostic Substances